This study evaluated the medication delivery performance of hypertonic saline when delivered via a nebulizer with breath actuated technology (inhalation) attached to an OPEP device (exhalation).
Bronchiectasis is a chronic, progressive lung condition affecting infants, children and adults. While the global prevalence of bronchiectasis is not accurately known,1 there is a growing awareness of the disease.2
